.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Cantor Fitzgerald
Cerilliant
AstraZeneca
QuintilesIMS
US Army
Cipla
Fuji
Harvard Business School
Accenture

Generated: December 17, 2017

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Germany Patent: 44 26 245

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Depomed IncNUCYNTAtapentadol hydrochlorideSOLUTION;ORAL203794-001Oct 15, 2012RXYesYes► Subscribe► SubscribeYYMANAGEMENT OF MODERATE TO SEVERE ACUTE PAIN
Depomed IncNUCYNTAtapentadol hydrochlorideTABLET;ORAL022304-001Nov 20, 2008RXYesNo► Subscribe► SubscribeYYRELIEF OF MODERATE TO SEVERE ACUTE PAIN
Depomed IncNUCYNTAtapentadol hydrochlorideTABLET;ORAL022304-002Nov 20, 2008RXYesNo► Subscribe► SubscribeYYRELIEF OF MODERATE TO SEVERE ACUTE PAIN
Depomed IncNUCYNTAtapentadol hydrochlorideTABLET;ORAL022304-003Nov 20, 2008RXYesYes► Subscribe► SubscribeYYRELIEF OF MODERATE TO SEVERE ACUTE PAIN
Depomed IncNUCYNTA ERtapentadol hydrochlorideTABLET, EXTENDED RELEASE;ORAL200533-001Aug 25, 2011RXYesNo► Subscribe► SubscribeYYMANAGEMENT OF NEUROPATHIC PAIN ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY
Depomed IncNUCYNTA ERtapentadol hydrochlorideTABLET, EXTENDED RELEASE;ORAL200533-001Aug 25, 2011RXYesNo► Subscribe► SubscribeYYRELIEF OF MODERATE TO SEVERE CHRONIC PAIN
Depomed IncNUCYNTA ERtapentadol hydrochlorideTABLET, EXTENDED RELEASE;ORAL200533-002Aug 25, 2011RXYesNo► Subscribe► SubscribeYYMANAGEMENT OF NEUROPATHIC PAIN ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY
Depomed IncNUCYNTA ERtapentadol hydrochlorideTABLET, EXTENDED RELEASE;ORAL200533-002Aug 25, 2011RXYesNo► Subscribe► SubscribeYYRELIEF OF MODERATE TO SEVERE CHRONIC PAIN
Depomed IncNUCYNTA ERtapentadol hydrochlorideTABLET, EXTENDED RELEASE;ORAL200533-003Aug 25, 2011RXYesNo► Subscribe► SubscribeYYMANAGEMENT OF NEUROPATHIC PAIN ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY
Depomed IncNUCYNTA ERtapentadol hydrochlorideTABLET, EXTENDED RELEASE;ORAL200533-003Aug 25, 2011RXYesNo► Subscribe► SubscribeYYRELIEF OF MODERATE TO SEVERE CHRONIC PAIN
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist